menu
    • menu

    Find Pimavanserin Tartrate manufacturers, exporters & distributors on PharmaCompass

    Evonik

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    19

    API Suppliers

    API Suppliers

    7

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    2

    EU WC

    EU WC

    0

    KDMF

    KDMF

    7

    NDC API

    NDC API

    0

    VMF

    NDC API

    15

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 12,934

    MARKET PLACE

    3

    API

    0

    FDF

    1INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    8

    FDF Dossiers

    FDF Dossiers

    8

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    26DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    19

    Others

    PATENTS & EXCLUSIVITIES

    30

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    56

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    528,932,689

    Annual Reports

    NA

    Finished Drug Prices

    NA

    76 RELATED EXCIPIENT COMPANIES

    138EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 706779-91-1, Acp-103, 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea, Pimavanserin [inn], Pimavanserin free base, Jz963p0dik
    Molecular Formula
    C25H34FN3O2
    Molecular Weight
    427.6  g/mol
    InChI Key
    RKEWSXXUOLRFBX-UHFFFAOYSA-N
    FDA UNII
    JZ963P0DIK
    Pimavanserin Tartrate
    Psychotic symptoms associated with Parkinson's disease (PD) are relatively common, reducing quality of life and prognosis for individuals with PD. Pimavanserin (ACP-103), marketed under the trade name Nuplazid, is a drug developed by Acadia Pharmaceuticals for the treatment of psychosis related to Parkinson's disease. Due to its actions at serotonin receptors and lack of effects on dopamine receptors, pimavanserin treats hallucinations and delusions without causing extrapyramidal symptoms. It was initially approved by the FDA in 2016 and is now under review as a potential treatment for dementia related psychosis. As of April 2021, FDA approval has not been granted for this indication, despite previous breakthrough designation.
    Pimavanserin is an Atypical Antipsychotic.
    1 2D Structure

    Pimavanserin Tartrate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
    2.1.2 InChI
    InChI=1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30)
    2.1.3 InChI Key
    RKEWSXXUOLRFBX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C
    2.2 Other Identifiers
    2.2.1 UNII
    JZ963P0DIK
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Acp 103

    2. Acp-103

    3. Acp103

    4. Bis(1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2r,3r)-2,3-dihydroxybutanedioate

    5. N-(4-fluorophenylmethyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide

    6. Nuplazid

    7. Pimavanserin Tartrate

    8. Urea, N-((4-fluorophenyl)methyl)-n-(1-methyl-4-piperidinyl)-n'-((4-(2-methylpropoxy)phenyl)methyl)-, (2r,3r)-2,3-dihydroxybutanedioate (2:1)

    2.3.2 Depositor-Supplied Synonyms

    1. 706779-91-1

    2. Acp-103

    3. 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea

    4. Pimavanserin [inn]

    5. Pimavanserin Free Base

    6. Jz963p0dik

    7. 706779-91-1 (free Base)

    8. 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea

    9. N-(4-fluorophenylmethyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl) Carbamide

    10. Unii-jz963p0dik

    11. N-(4-fluorophenylmethyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide

    12. 706782-28-7

    13. Pimanavserin

    14. Methyltrimethylacetate

    15. Ac-5273

    16. Pimavanserin [mi]

    17. Pimavanserin(acp-103)

    18. Pimavanserin [who-dd]

    19. Schembl675165

    20. Nuplazid (proposed Trade Name)

    21. Gtpl8423

    22. Chembl2111101

    23. Dtxsid90990906

    24. Chebi:133017

    25. Bdbm139370

    26. Hms3742a03

    27. Bcp11618

    28. Ex-a4895

    29. Mfcd09953792

    30. Zinc16159083

    31. Akos015902593

    32. Cs-3378

    33. Db05316

    34. Me-0240

    35. Sb16963

    36. Ncgc00390656-01

    37. Ncgc00390656-02

    38. Hy-14557

    39. B8019

    40. Ft-0653701

    41. A14434

    42. 779p911

    43. A836958

    44. J-503297

    45. Q7194603

    46. N-[(4-fluorophenyl)methyl]-n-(1-methyl-4-piperidinyl)-n'-[[4-(2-methylpropoxy)phenyl]methyl]urea;

    47. N-[(4-fluorophenyl)methyl]-n-(1-methylpiperidin-4-yl)-n'-{[4-(2-methylpropoxy)phenyl]methyl}urea

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 427.6 g/mol
    Molecular Formula C25H34FN3O2
    XLogP34.5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count8
    Exact Mass427.26350550 g/mol
    Monoisotopic Mass427.26350550 g/mol
    Topological Polar Surface Area44.8 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity523
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Pimavanserin is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis.

    Treatment of schizophrenia and other psychotic disorders

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Pimavanserin's unique actions on serotonin receptors improve symptoms of hallucinations and delusions associated with Parkinson's disease. In clinical studies, 80.5% of individuals treated with pimavanserin reported improvement in symptoms. Pimavanserin does not worsen motor functioning in patients with Parkinson's disease psychosis.

    5.2 MeSH Pharmacological Classification

    Antiparkinson Agents

    Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)

    Antipsychotic Agents

    Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)

    Serotonin 5-HT2 Receptor Antagonists

    Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes. (See all compounds classified as Serotonin 5-HT2 Receptor Antagonists.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    PIMAVANSERIN
    5.3.2 FDA UNII
    JZ963P0DIK
    5.3.3 Pharmacological Classes
    Established Pharmacologic Class [EPC] - Atypical Antipsychotic
    5.4 ATC Code

    N - Nervous system

    N05 - Psycholeptics

    N05A - Antipsychotics

    N05AX - Other antipsychotics

    N05AX17 - Pimavanserin

    5.5 Absorption, Distribution and Excretion

    Absorption

    The median Tmax of pimavanserin in clinical studies was 6 hours, regardless of the dose. Bioavailability of an oral tablet of pimavanserin and a solution were almost identical. The major active circulating N-desmethylated metabolite, AC-279, has a median Tmax of 6 hours.

    Route of Elimination

    About 0.55% of a 34 mg oral dose was excreted unchanged in the urine and 1.53% was eliminated in feces within 10 days. Less than 1% of the administered dose and its active metabolite AC-279 were recovered in urine during clinical studies.

    Volume of Distribution

    Following administration of a single dose of 34 mg, the average apparent volume of distribution was 2173 L in clinical studies.

    5.6 Metabolism/Metabolites

    Pimavanserin is mainly metabolized CYP3A4 and CYP3A5 hepatic cytochrome enzymes, and to a lesser extent by CYP2J2, CYP2D6, and other cytochrome and flavin-containing monooxygenase enzymes. CYP3A4 metabolizes pimavanserin to its major active metabolite, AC-279.

    5.7 Biological Half-Life

    The average plasma half-lives for pimavanserin and its active metabolite (AC-279) are estimated at 57 hours and 200 hours, respectively.

    5.8 Mechanism of Action

    Parkinson's disease psychosis (PDP) is a imbalance of serotonin and dopamine from disruption of the normal balance between the serotonergic and dopaminergic receptors and neurotransmitters in the brain. The mechanism by which pimavanserin treats hallucinations and delusions associated with Parkinsons disease psychosis is not fully established. It is possible that pimavanserin acts via inverse agonist and antagonist activity at serotonin 5-HT2A receptors with limited effects on serotonin 5-HT2C receptors. Pimavanserin is an inverse agonist and antagonist of serotonin 5-HT2A receptors with high binding affinity, demonstrating low binding affinity to serotonin 5-HT2C receptors. In addition, this drug exhibits low affinity binding to sigma 1 receptors. Pimavanserin lacks activity at muscarinic, dopaminergic, adrenergic, and histaminergic receptors, preventing various undesirable effects typically associated with antipsychotics.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"PIMAVANSERIN TARTRATE","year":"2021","qtr":"Q1","strtotime":1617129000,"product":"PIMAVANSERIN TARTRATE IH","address":"H.NO. 8-3-166\/182, A BLOCK, NORTH WING, 105-108, FIRST FLOOR,","city":"CHALLA ESTATES, HYDERABAD,TELANGANA","supplier":"DASAMI LAB PRIVATE ","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"GLOBAL NAPI PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"1578.4","totalValueFC":"78.1","currency":"USD","unitRateINR":113725.59999999999,"date":"31-Mar-2021","totalValueINR":"5686.28","totalValueInUsd":"78.1","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"9782483","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-3-166\/182, A BLOCK, NORTH WING, 105-108, FIRST FLOOR,, CHALLA ESTATES, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623436200,"product":"PIMAVANSERIN TARTRATE (TAX INV NO:BPCI\/2 1-22\/04E DT:04\/06\/2021","address":"PLOT?NO.?193,?HOUSE?NO.?5-35\/50,PRASHANT?NAGAR,?KUKATPALLY,","city":"HYDERABAD,?AP","supplier":"BIOPHORE INDIA PHARMACEUTICALS PVT LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"PHARMACTIVE ILAC SAN ","customerCountry":"TURKEY","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"15956.3","totalValueFC":"31263.5","currency":"USD","unitRateINR":1149648.5,"date":"12-Jun-2021","totalValueINR":"2299297","totalValueInUsd":"31263.5","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"2373706","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT?NO.?193,?HOUSE?NO.?5-35\/50,PRASHANT?NAGAR,?KUKATPALLY,, HYDERABAD,?AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1631903400,"product":"PIMAVANSERIN TARTRATE (TAX INV NO:BPVCI","address":"PLOT?NO.?193,?HOUSE?NO.?5-35\/50,PRASHANT?NAGAR,?KUKATPALLY,","city":"HYDERABAD,?AP","supplier":"BIOPHORE INDIA PHARMACEUTICALS PVT LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ARDI FARMA ILAC PAZARLAMA TICARET LTD STI","customerCountry":"TURKEY","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"15000","totalValueFC":"7286.9","currency":"USD","unitRateINR":1072000,"date":"18-Sep-2021","totalValueINR":"536000","totalValueInUsd":"7286.9","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"4687210","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT?NO.?193,?HOUSE?NO.?5-35\/50,PRASHANT?NAGAR,?KUKATPALLY,, HYDERABAD,?AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646245800,"product":"PIMAVANSERIN TARTRATE IH","address":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE ","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"BAGO GROUP","customerCountry":"ARGENTINA","quantity":"18.00","actualQuantity":"18","unit":"KGS","unitRateFc":"1794.5","totalValueFC":"30202.2","currency":"USD","unitRateINR":127888.88888888889,"date":"03-Mar-2022","totalValueINR":"2302000","totalValueInUsd":"30202.2","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"8671985","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648405800,"product":"PIMAVANSERIN TARTRATE (II)","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"PHARMACTIVE YLAC SAN. VE TIC.A.S","customerCountry":"TURKEY","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"15000","totalValueFC":"2965.1","currency":"USD","unitRateINR":1130000,"date":"28-Mar-2022","totalValueINR":"226000","totalValueInUsd":"2965.1","indian_port":"HYDERABAD AIR","hs_no":"29333200","bill_no":"9267682","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD, HYDERABAD TS","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689791400,"product":"PIMAVANSERIN TARTRATE","address":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE ","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER OF,","customerCountry":"TURKEY","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"10000","totalValueFC":"2482.1","currency":"USD","unitRateINR":815999.18400000001,"date":"20-Jul-2023","totalValueINR":"203999.796","totalValueInUsd":"2482.1","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721068200,"product":"PIMAVANSERIN TARTRATE IH","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE ","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO THE ORDER OF","customerCountry":"ARGENTINA","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"1700","totalValueFC":"13449","currency":"USD","unitRateINR":140527.5,"date":"16-Jul-2024","totalValueINR":"1124220","totalValueInUsd":"13449","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"2447991","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""}]
    31-Mar-2021
    16-Jul-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Granulation

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Topical

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search